Pharmaceutical companyLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field. in SwitzerlandLabelled by claude-haiku-5.5 from the firm's FDA names. It is not an FDA field.. FDA records under its name, each linked to the record.
As of Nov 22, 2026, FDA's public records list Galderma R&D with 1 complete response letter. The most recent is a complete response letter dated Sep 29, 2023: Complete response letter, BLA 761311.
Drug approvals, 510(k) clearances, recalls and letters, 2023 to 2026 to date
A hatched bar is a year that is not over, so its count covers only part of the year.
| Date | Record | Source |
|---|---|---|
| Sep 29, 2023 | Complete response letter, BLA 761311Unapproved | Complete response letter |
Spellings are joined only when they reduce to the same name, or a reviewed source names the same company. Sharing an FDA establishment number (FEI) is not enough: contract sites make products for many firms. Facts marked AI were labelled by a language model from the firm's FDA names; everything else comes from FDA or Wikidata.